NEEDHAM, MA - Feb 28, 2014 - Cambridge Healthtech Institute's Insight Pharma Affiliated Reports Collection announces The Impact of Mobile Health on Patient-Centric Disease Management, published by FirstWord Reports.

Through The Impact of Mobile Health on Patient-Centric Disease Management, FirstWord explores the emerging and exciting world of mobile and digital health apps. Based on interviews from nine industry experts, reviews of clinical and commercial opportunities and case studies, the report offers insight into app development, integration, and how the industry can capture the market now and in the future. 

 Key Report Features of The Impact of Mobile Health on Patient-Centric Disease Management include: 

 -Expert opinion from those working at the forefront of the emerging mHealth industry, including experts from GlaxoSmithKline, Boehringer Ingelheim, UCB and Janssen Healthcare 

 -Overview of clinical and commercial opportunities and realities. with implications for patients, clinicians and pharma 

 -Case studies of new, established and successful platforms, covering diabetes, schizophrenia, adherence, cognitive behavioural therapy and epilepsy 

 -Insight into the use of data for clinical patient management  

For more information and to purchase this Insight Pharma Report, visit: www.InsightPharmaReports.com

About Insight Pharma Reports

Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace. Insight Pharma Reports is a division within Cambridge Healthtech Institute.  www.InsightPharmaReports.com

Insight Pharma Reports offers ourAffiliated Reports Collectionwhich provides a repository of additional scientific and business resources. For more information, visithttp://www.insightpharmareports.com/affiliatedreports/